Epidermal Growth Factor Receptor Status in Circulating Tumor Cells as a Predictive Biomarker of Sensitivity in Castration-Resistant Prostate Cancer Patients Treated with Docetaxel Chemotherapy

Objective: We examined whether epidermal growth factor receptor (EGFR) expression in circulating tumor cells (CTCs) can be used to predict survival in a population of bone-metastatic castration-resistant prostate cancer (mCRPC) patients treated with docetaxel chemotherapy. Methods: All patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Okegawa, Takatsugu, Itaya, Naoshi, Hara, Hidehiko, Tambo, Mitsuhiro, Nutahara, Kikuo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187808/
https://www.ncbi.nlm.nih.gov/pubmed/27916908
http://dx.doi.org/10.3390/ijms17122008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5187808/
https://www.ncbi.nlm.nih.gov/pubmed/27916908
http://dx.doi.org/10.3390/ijms17122008

Ejemplares similares